SCHEMBL24251412

SCHEMBL24251412

Cc1nn2c(C(C)C)c(C(=O)N[C@@H](C)c3ccccc3)ccc2c1-c1c(F)cccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ MAPT P10636 2/20 0.44
▸ GAA P10253 2/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ PDE2A O00408 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ DCTPP1 Q9H773 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24251422 0.94 ALDH1A1 (0.46) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL24251388 0.90 PDE2A (0.43) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL24251556 0.90 PDE2A (0.43) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL24251582 0.89 PPARG (0.46) ALDH1A1KDM4ELMNAHPGDHSD17B10
SCHEMBL24251405 0.87 ROCK2 (0.35) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL24251585 0.87 RIPK1 (0.42) MEN1KMT2AALDH1A1
SCHEMBL24251401 0.86 MEN1 (0.43) MEN1KMT2AGAALMNACNR2
SCHEMBL24251371 0.86 KMT2A (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24251590 0.86 MAPK1 (0.40) MEN1KMT2AMAPTGAALMNA
SCHEMBL23355438 0.84 PDE4B (0.35) MAPTALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048903-A1 Anthelminthic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048903-A1 Anthelminthic Heterocyclic Compounds SDHA, PAH, PIGS MEN1 2676/4885KMT2A 1440/4885MAPT 3681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback